This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Chlamydia trachomatis Lipopolysaccharides (LPS) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for Chlamydia trachomatis lipopolysaccharides. It can be applied to ELISA of Chlamydia trachomatis lipopolysaccharides.
Specifications
Target Information
Chlamydia trachomatis, a Gram-negative intracellular bacterium, is known for its ability to evade the host immune system, partly due to its unique lipopolysaccharides (LPS). LPS is a major component of the outer membrane of Gram-negative bacteria and plays a significant role in the pathogen's virulence and immune evasion. The LPS of Chlamydia trachomatis is structurally distinct from that of other bacteria, with modifications that reduce its immunogenicity. This allows the bacterium to dampen the host's inflammatory response, facilitating its intracellular survival and replication. The lipid A component of the LPS is particularly important for its endotoxic properties, which can trigger a cascade of immune responses if not effectively managed.
Shipping and Storage
This product is shipped with ice gel packs. Store at -20°C - -70°C(up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Rund, Sabine, et al. "Structural Analysis of the Lipopolysaccharide fromChlamydia trachomatis Serotype L2." Journal of Biological Chemistry 274.24 (1999): 16819-16824.